1,239
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Symptomatic Uncomplicated Diverticular Disease (SUDD): Practical Guidance and Challenges for Clinical Management

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & show all
Pages 29-43 | Received 21 Jan 2023, Accepted 18 Mar 2023, Published online: 28 Mar 2023

References

  • Everhart JE, Ruhl CE. Burden of digestive diseases in the united states part ii: lower gastrointestinal diseases. Gastroenterology. 2009;136(3):741–754. doi:10.1053/j.gastro.2009.01.015
  • Rezapour M, Ali S, Stollman N. Diverticular disease: an update on pathogenesis and management. Gut Liver. 2018;12(2):125–132. doi:10.5009/gnl16552
  • Scarpignato C, Barbara G, Lanas A, Strate LL. Management of colonic diverticular disease in the third millennium: highlights from a symposium held during the United European Gastroenterology Week 2017. Therap Adv Gastroenterol. 2018;11:1756284818771305. doi:10.1177/1756284818771305
  • Tursi A, Brandimarte G, Di Mario F, et al. International consensus on diverticulosis and diverticular disease. statements from the 3rd international symposium on diverticular disease. J Gastrointestin Liver Dis. 2019;28(suppl. 4):57–66. doi:10.15403/jgld-562
  • Cuomo R, Barbara G, Pace F, et al. Italian consensus conference for colonic diverticulosis and diverticular disease. United Eur Gastroenterol J. 2014;2(5):413–442. doi:10.1177/2050640614547068
  • Binda GA, Cuomo R, Laghi A, et al. Practice parameters for the treatment of colonic diverticular disease: Italian Society of Colon and Rectal Surgery (SICCR) guidelines. Tech Coloproctol. 2015;19(10):615–626. doi:10.1007/s10151-015-1370-x
  • Schultz JK, Azhar N, Binda GA, et al. European Society of Coloproctology: guidelines for the management of diverticular disease of the colon. Colorectal Dis. 2020;22(Suppl 2):5–28. doi:10.1111/codi.15140
  • Comparato G, Fanigliulo L, Aragona G, et al. Quality of life in uncomplicated symptomatic diverticular disease: is it another good reason for treatment? Dig Dis. 2007;25(3):252–259. doi:10.1159/000103896
  • Spiegel BMR, Reid MW, Bolus R, et al. Development and validation of a disease-targeted quality of life instrument for chronic diverticular disease: the DV-QOL. Qual Life Res. 2015;24(1):163–179. doi:10.1007/s11136-014-0753-1
  • Tursi A, Franceschi M, Elisei W, Picchio M, Di Mario F, Brandimarte G. The natural history of symptomatic uncomplicated diverticular disease: a long-term follow-up study. AOG. 2020. doi:10.20524/aog.2020.0560
  • Baethge C, Goldbeck-Wood S, Mertens S. SANRA—a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4(1):5. doi:10.1186/s41073-019-0064-8
  • Oxford Centre for Evidence-Based Medicine. OCEBM Levels of Evidence Working Group*. The oxford levels of evidence 2. OCEBM - Oxford Centre for Evidence-Based Medicine. Available from: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence. Accessed December 3, 2022.
  • Jung HK, Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenterol. 2010;105(3):652–661. doi:10.1038/ajg.2009.621
  • Cuomo R, Barbara G, Andreozzi P, et al. Symptom patterns can distinguish diverticular disease from irritable bowel syndrome. Eur J Clin Invest. 2013;43(11):1147–1155. doi:10.1111/eci.12152
  • Tursi A, Picchio M, Giorgetti GM, Brandimarte G. Moderate to severe and prolonged left lower-abdominal pain is the best symptom characterizing symptomatic uncomplicated diverticular disease of the colon: a comparison with fecal calprotectin in clinical setting. J Clin Gastroenterol. 2015;49(3):218–221. doi:10.1097/MCG.0000000000000094
  • Tursi A, Scarpignato C. Symptomatic uncomplicated diverticular disease: chronic abdominal pain in diverticulosis is not enough to make the diagnosis. Clin Gastroenterol Hepatol. 2018;16(12):2001–2002. doi:10.1016/j.cgh.2018.06.033
  • Tursi A, Brandimarte G, Elisei W, Giorgetti GM, Inchingolo CD, Aiello F. Faecal calprotectin in colonic diverticular disease: a case–control study. Int J Colorectal Dis. 2009;24(1):49–55. doi:10.1007/s00384-008-0595-9
  • Salem TA, Molloy RG, O’Dwyer PJ. Prospective, five-year follow-up study of patients with symptomatic uncomplicated diverticular disease. Dis Colon Rectum. 2007;50(9):1460–1464. doi:10.1007/s10350-007-0226-5
  • Carabotti M, Cuomo R, Barbara G, Pace F, Andreozzi P, Annibale B. Five-year Italian Registry of Diverticulosis and Diverticular Disease (Remad): a low progression rate of disease during the first year of follow-up. EMJ. 2017;6(1):42–44.
  • Horgan AF, McConnell EJ, Wolff BG, The S, Paterson C. Atypical diverticular disease: surgical results. Dis Colon Rectum. 2001;44(9):1315–1318. doi:10.1007/BF02234790
  • Boostrom SY, Wolff BG, Cima RR, Merchea A, Dozois EJ, Larson DW. Uncomplicated diverticulitis, more complicated than we thought. J Gastrointest Surg. 2012;16(9):1744–1749. doi:10.1007/s11605-012-1924-4
  • Mari GM, Crippa J, Borroni G, et al. Symptomatic uncomplicated diverticular disease and incidence of unexpected abscess during sigmoidectomy: a multicenter prospective observational study. Dig Surg. 2020;37(3):199–204. doi:10.1159/000500084
  • Tursi A, Elisei W, Franceschi M, Picchio M, Di Mario F, Brandimarte G. The prevalence of symptomatic uncomplicated diverticular disease could be lower than expected: a single-center colonoscopy-based cohort study. Eur J Gastroenterol Hepatol. 2021;33(1S):e478. doi:10.1097/MEG.0000000000002142
  • Stollman N, Raskin JB. Diverticular disease of the colon. Lancet. 2004;363(9409):631–639. doi:10.1016/S0140-6736(04)15597-9
  • Peery AF, To K, Ja G, Rs S. Colonic diverticulosis is not associated with painful abdominal symptoms in a US population. Gastro Hep Adv. 2022;1(4):659–665. doi:10.1016/j.gastha.2022.04.001
  • Peery AF, Keku TO, Addamo C, et al. Colonic diverticula are not associated with mucosal inflammation or chronic gastrointestinal symptoms. Clin Gastroenterol Hepatol. 2018;16(6):884–891.e1. doi:10.1016/j.cgh.2017.05.051
  • Granlund J, Svensson T, Olén O, et al. The genetic influence on diverticular disease--a twin study. Aliment Pharmacol Ther. 2012;35(9):1103–1107. doi:10.1111/j.1365-2036.2012.05069.x
  • Strate LL, Erichsen R, Baron JA, et al. Heritability and familial aggregation of diverticular disease: a population-based study of twins and siblings. Gastroenterology. 2013;144(4):736–742.e1; quiz e14. doi:10.1053/j.gastro.2012.12.030
  • Camilleri M, Sandler RS, Peery AF. Etiopathogenetic mechanisms in diverticular disease of the colon. Cell Mol Gastroenterol Hepatol. 2020;9(1):15–32. doi:10.1016/j.jcmgh.2019.07.007
  • Maguire LH, Handelman SK, Du X, Chen Y, Pers TH, Speliotes EK. Genome-wide association analyses identify 39 new susceptibility loci for diverticular disease. Nat Genet. 2018;50(10):1359–1365. doi:10.1038/s41588-018-0203-z
  • Sigurdsson S, Alexandersson KF, Sulem P, et al. Sequence variants in ARHGAP15, COLQ and FAM155A associate with diverticular disease and diverticulitis. Nat Commun. 2017;8:15789. doi:10.1038/ncomms15789
  • Aldoori WH, Giovannucci EL, Rimm EB, et al. Prospective study of physical activity and the risk of symptomatic diverticular disease in men. Gut. 1995;36(2):276–282. doi:10.1136/gut.36.2.276
  • Aune D, Sen A, Leitzmann MF, Norat T, Tonstad S, Vatten LJ. Body mass index and physical activity and the risk of diverticular disease: a systematic review and meta-analysis of prospective studies. Eur J Nutr. 2017;56(8):2423–2438. doi:10.1007/s00394-017-1443-x
  • Williams PT. Incident diverticular disease is inversely related to vigorous physical activity. Med Sci Sports Exerc. 2009;41(5):1042–1047. doi:10.1249/MSS.0b013e318192d02d
  • Strate LL, Morris AM. Epidemiology, Pathophysiology, and Treatment of Diverticulitis. Gastroenterology. 2019;156(5):1282–1298.e1. doi:10.1053/j.gastro.2018.12.033
  • Barbaro MR, Cremon C, Fuschi D, et al. Pathophysiology of diverticular disease: from diverticula formation to symptom generation. Int J Mol Sci. 2022;23(12):6698. doi:10.3390/ijms23126698
  • Peery AF, Sandler RS, Ahnen DJ, et al. Constipation and a low-fiber diet are not associated with diverticulosis. Clin Gastroenterol Hepatol. 2013;11(12):1622–1627. doi:10.1016/j.cgh.2013.06.033
  • Aldoori WH, Giovannucci EL, Rockett HR, Sampson L, Rimm EB, Willett WC. A prospective study of dietary fiber types and symptomatic diverticular disease in men. J Nutr. 1998;128(4):714–719. doi:10.1093/jn/128.4.714
  • Crowe FL, Balkwill A, Cairns BJ, et al. Source of dietary fibre and diverticular disease incidence: a prospective study of UK women. Gut. 2014;63(9):1450–1456. doi:10.1136/gutjnl-2013-304644
  • Crowe FL, Appleby PN, Allen NE, Key TJ. Diet and risk of diverticular disease in Oxford cohort of European Prospective Investigation into Cancer and Nutrition (EPIC): prospective study of British vegetarians and non-vegetarians. BMJ. 2011;343:d4131. doi:10.1136/bmj.d4131
  • Strate LL, Liu YL, Syngal S, Aldoori WH, Giovannucci EL. Nut, corn, and popcorn consumption and the incidence of diverticular disease. JAMA. 2008;300(8):907–914. doi:10.1001/jama.300.8.907
  • Aldoori WH, Giovannucci EL, Rimm EB, Wing AL, Trichopoulos DV, Willett WC. A prospective study of alcohol, smoking, caffeine, and the risk of symptomatic diverticular disease in men. Ann Epidemiol. 1995;5(3):221–228. doi:10.1016/1047-2797(94)00109-7
  • Hjern F, Wolk A, Håkansson N. Smoking and the risk of diverticular disease in women. Br J Surg. 2011;98(7):997–1002. doi:10.1002/bjs.7477
  • Longo S, Altobelli E, Castellini C, et al. Non-steroidal anti-inflammatory drugs and acetylsalicylic acid increase the risk of complications of diverticular disease: a meta-analysis of case-control and cohort studies. Int J Colorectal Dis. 2022;37(3):521–529. doi:10.1007/s00384-021-04088-1
  • Barbara G, Scaioli E, Barbaro MR, et al. Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease. Gut. 2017;66(7):1252–1261. doi:10.1136/gutjnl-2016-312377
  • Scaioli E, Colecchia A, Marasco G, Schiumerini R, Festi D. Pathophysiology and therapeutic strategies for symptomatic uncomplicated diverticular disease of the colon. Dig Dis Sci. 2016;61(3):673–683. doi:10.1007/s10620-015-3925-0
  • Humes DJ, Simpson J, Smith J, et al. Visceral hypersensitivity in symptomatic diverticular disease and the role of neuropeptides and low grade inflammation. Neurogastroenterol Motil. 2012;24(4):318–e163. doi:10.1111/j.1365-2982.2011.01863.x
  • Kvasnovsky CL, Leong LEX, Choo JM, et al. Clinical and symptom scores are significantly correlated with fecal microbiota features in patients with symptomatic uncomplicated diverticular disease: a pilot study. Eur J Gastroenterol Hepatol. 2018;30(1):107–112. doi:10.1097/MEG.0000000000000995
  • Tursi A, Mastromarino P, Capobianco D, et al. Assessment of fecal microbiota and fecal metabolome in symptomatic uncomplicated diverticular disease of the colon. J Clin Gastroenterol. 2016;50(Suppl 1):S9–S12. doi:10.1097/MCG.0000000000000626
  • Tursi A, Papa V, Lopetuso LR, Settanni CR, Gasbarrini A, Papa A. Microbiota composition in diverticular disease: implications for therapy. Int J Mol Sci. 2022;23(23):14799. doi:10.3390/ijms232314799
  • Piscopo N, Ellul P. Diverticular disease: a review on pathophysiology and recent evidence. Ulster Med J. 2020;89(2):83–88. doi:10.1136/bmj.d4131
  • Zullo A. Medical hypothesis: speculating on the pathogenesis of acute diverticulitis. Ann Gastroenterol. 2018;31(6):747–749. doi:10.20524/aog.2018.0315
  • Golder M, Ster IC, Babu P, Sharma A, Bayat M, Farah A. Demographic determinants of risk, colon distribution and density scores of diverticular disease. World J Gastroenterol. 2011;17(8):1009–1017. doi:10.3748/wjg.v17.i8.1009
  • Altomare A, Gori M, Cocca S, et al. Impaired Colonic Contractility and Intestinal Permeability in Symptomatic Uncomplicated Diverticular Disease. J Neurogastroenterol Motil. 2021;27(2):292–301. doi:10.5056/jnm20110
  • Bassotti G, Villanacci V, Nascimbeni R, et al. The role of colonic mast cells and myenteric plexitis in patients with diverticular disease. Int J Colorectal Dis. 2013;28(2):267–272. doi:10.1007/s00384-012-1554-z
  • Bassotti G, Battaglia E, Bellone G, et al. Interstitial cells of Cajal, enteric nerves, and glial cells in colonic diverticular disease. J Clin Pathol. 2005;58(9):973–977. doi:10.1136/jcp.2005.026112
  • Iwase H, Sadahiro S, Mukoyama S, Makuuchi H, Yasuda M. Morphology of myenteric plexuses in the human large intestine: comparison between large intestines with and without colonic diverticula. J Clin Gastroenterol. 2005;39(8):674–678. doi:10.1097/01.mcg.0000173856.84814.37
  • Bassotti G, Villanacci V, Bernardini N, Dore MP. Diverticular disease of the colon: neuromuscular function abnormalities. J Clin Gastroenterol. 2016;50:S6. doi:10.1097/MCG.0000000000000578
  • Mischopoulou M, D’Ambrosio M, Bigagli E, Luceri C, Farrugia G, Cipriani G. Role of macrophages and mast cells as key players in the maintenance of gastrointestinal smooth muscle homeostasis and disease. Cell Mol Gastroenterol Hepatol. 2022;13(6):1849–1862. doi:10.1016/j.jcmgh.2022.02.017
  • Lanas A, Abad-Baroja D, Lanas-Gimeno A. Progress and challenges in the management of diverticular disease: which treatment? Therap Adv Gastroenterol. 2018;11:1756284818789055. doi:10.1177/1756284818789055
  • Maconi G, Carmagnola S, Guzowski T. Intestinal Ultrasonography in the diagnosis and management of colonic diverticular disease. J Clin Gastroenterol. 2016;50(Suppl 1):S20–22. doi:10.1097/MCG.0000000000000657
  • Khor S, Flum DR, Strate LL, et al. Establishing clinically significant patient-reported outcomes for diverticular disease. J Surg Res. 2021;264:20–29. doi:10.1016/j.jss.2021.01.045
  • Lahat A, Fidder HH, Ben-Horin S. Development and validation of a diverticular clinical score for symptomatic uncomplicated diverticular disease after acute diverticulitis in a prospective patient cohort. Therap Adv Gastroenterol. 2020;13:1756284820913210. doi:10.1177/1756284820913210
  • De Vincentis A, Santonico M, Del Chierico F, et al. Gut microbiota and related electronic multisensorial system changes in subjects with symptomatic uncomplicated diverticular disease undergoing rifaximin therapy. Front Med. 2021;8:655474. doi:10.3389/fmed.2021.655474
  • Cuomo R. Diverticular disease register (REMAD). clinicaltrials.gov; 2017. Available from: https://clinicaltrials.gov/ct2/show/NCT03325829. Accessed December 6, 2022.
  • Origi M, Achilli P, Calini G, et al. The Diverticular Disease Registry (DDR Trial) by the advanced international mini-invasive surgery academy clinical research network: protocol for a multicenter, prospective observational study. Int J Surg Protoc. 2021;25(1):194–200. doi:10.29337/ijsp.157
  • Justin V, Uranues S, Rabl H, Fingerhut A. Quality of life in uncomplicated recurrent diverticulitis: surgical vs. conservative treatment. Sci Rep. 2020;10(1):10261. doi:10.1038/s41598-020-67094-3
  • Mari GM, Crippa J, Roscio F, et al. Quality of life after elective laparoscopic sigmoidectomy for symptomatic uncomplicated diverticular disease. Surg Laparosc Endosc Percutan Tech. 2021;31(2):193–195. doi:10.1097/SLE.0000000000000860
  • Hawkins AT, Wise PE, Chan T, et al. Diverticulitis: an update from the age old paradigm. Curr Probl Surg. 2020;57(10):100862. doi:10.1016/j.cpsurg.2020.100862
  • Eberhardt F, Crichton M, Dahl C, et al. Role of dietary fibre in older adults with asymptomatic (AS) or symptomatic uncomplicated diverticular disease (SUDD): systematic review and meta-analysis. Maturitas. 2019;130:57–67. doi:10.1016/j.maturitas.2019.10.006
  • Carabotti M, Annibale B, Severi C, Lahner E. Role of fiber in symptomatic uncomplicated diverticular disease: a systematic review. Nutrients. 2017;9(2):161. doi:10.3390/nu9020161
  • Andersen JC, Bundgaard L, Elbrønd H, et al. Danish national guidelines for treatment of diverticular disease. Dan Med J. 2012;59(5):C4453.
  • Cuomo R, Barbara G, Annibale B. Rifaximin and diverticular disease: position paper of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis. 2017;49(6):595–603. doi:10.1016/j.dld.2017.01.164
  • Pietrzak A, Bartnik W, Szczepkowski M, et al. Polish interdisciplinary consensus on diagnostics and treatment of colonic diverticulosis (2015). Pol Przegl Chir. 2015;87(4):203–220. doi:10.1515/pjs-2015-0045
  • Kvasnovsky CL, Bjarnason I, Donaldson AN, Sherwood RA, Papagrigoriadis S. A randomized double-blind placebo-controlled trial of a multi-strain probiotic in treatment of symptomatic uncomplicated diverticular disease. Inflammopharmacology. 2017;25(5):499–509. doi:10.1007/s10787-017-0363-y
  • Tursi A, Brandimarte G, Elisei W, et al. Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease – a double-blind, randomised, placebo-controlled study. Aliment Pharmacol Ther. 2013;38(7):741–751. doi:10.1111/apt.12463
  • Tursi A, Brandimarte G, Giorgetti GM, Elisei W. Mesalazine and/or Lactobacillus casei in maintaining long-term remission of symptomatic uncomplicated diverticular disease of the colon. Hepatogastroenterology. 2008;55(84):916–920.
  • Tursi A, Brandimarte G, Giorgetti GM, Elisei W. Mesalazine and/or lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study. J Clin Gastroenterol. 2006;40(4):312–316. doi:10.1097/01.mcg.0000210092.77296.6d
  • Annibale B, Maconi G, Lahner E, Giorgi F, Cuomo R. Efficacy of Lactobacillus paracasei sub. paracasei F19 on abdominal symptoms in patients with symptomatic uncomplicated diverticular disease: a pilot study. Minerva Gastroenterol Dietol. 2011;57:13–22.
  • Lahner E, Esposito G, Zullo A, et al. High-fibre diet and Lactobacillus paracasei B21060 in symptomatic uncomplicated diverticular disease. World J Gastroenterol. 2012;18(41):5918–5924. doi:10.3748/wjg.v18.i41.5918
  • Lamiki P, Tsuchiya J, Pathak S, et al. Probiotics in diverticular disease of the colon: an open label study. J Gastrointestin Liver Dis. 2010;19(1):31–36.
  • Lahner E, Bellisario C, Hassan C, Zullo A, Esposito G, Annibale B. Probiotics in the treatment of diverticular disease. a systematic review. J Gastrointestin Liver Dis. 2016;25(1):79–86. doi:10.15403/jgld.2014.1121.251.srw
  • Hall J, Hardiman K, Lee S, et al. The American Society of colon and rectal surgeons clinical practice guidelines for the treatment of left-sided colonic diverticulitis. Dis Colon Rectum. 2020;63(6):728–747. doi:10.1097/DCR.0000000000001679
  • Khan RMA, Ali B, Hajibandeh S, Hajibandeh S. Effect of mesalazine on recurrence of diverticulitis in patients with symptomatic uncomplicated diverticular disease: a meta-analysis with trial sequential analysis of randomized controlled trials. Colorectal Dis. 2018;20(6):469–478. doi:10.1111/codi.14064
  • Iannone A, Ruospo M, Wong G, et al. Mesalazine for people with diverticular disease: a systematic review of randomized controlled trials. Can J Gastroenterol Hepatol. 2018;2018:5437135. doi:10.1155/2018/5437135
  • Picchio M. Mesalazine to treat symptomatic uncomplicated diverticular disease and to prevent acute diverticulitis occurrence. A systematic review with meta-analysis of randomized, placebo-controlled trials. J Gastrointest Liver Dis. 2018;27(3). doi:10.15403/jgld.2014.1121.273.pic
  • Carabotti M, Annibale B. Treatment of diverticular disease: an update on latest evidence and clinical implications. Drugs Context. 2018;7:212526. doi:10.7573/dic.212526
  • Maconi G, Barbara G, Bosetti C, Cuomo R, Annibale B. Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review. Dis Colon Rectum. 2011;54(10):1326–1338. doi:10.1097/DCR.0b013e318223cb2b
  • Bianchi M, Festa V, Moretti A, et al. Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease. Aliment Pharmacol Ther. 2011;33(8):902–910. doi:10.1111/j.1365-2036.2011.04606.x
  • Colecchia A, Vestito A, Pasqui F, et al. Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease. World J Gastroenterol. 2007;13(2):264–269. doi:10.3748/wjg.v13.i2.264
  • Comparato G, Fanigliulo L, Cavallaro LG, et al. Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up. Dig Dis Sci. 2007;52(11):2934–2941. doi:10.1007/s10620-007-9766-8
  • Di Mario F, Aragona G, Leandro G, et al. Efficacy of mesalazine in the treatment of symptomatic diverticular disease. Dig Dis Sci. 2005;50(3):581–586. doi:10.1007/s10620-005-2478-z
  • D’Incà R, Pomerri F, Vettorato MG, et al. Interaction between rifaximin and dietary fibre in patients with diverticular disease. Aliment Pharmacol Ther. 2007;25(7):771–779. doi:10.1111/j.1365-2036.2007.03266.x
  • Latella G, Pimpo MT, Sottili S, et al. Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis. 2003;18(1):55–62. doi:10.1007/s00384-002-0396-5
  • Papi C, Ciaco A, Koch M, Capurso L. Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther. 1995;9(1):33–39. doi:10.1111/j.1365-2036.1995.tb00348.x
  • Papi C, Ciaco A, Koch M, Capurso L. Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group. Ital J Gastroenterol. 1992;24(8):452–456.
  • Tursi A, Brandimarte G, Daffinà R. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis. 2002;34(7):510–515. doi:10.1016/s1590-8658(02)80110-4
  • Di Mario F, Miraglia C, Cambiè G, et al. Long-term efficacy of rifaximin to manage the symptomatic uncomplicated diverticular disease of the colon. J Investig Med. 2019;67(4):767–770. doi:10.1136/jim-2018-000901
  • Stallinger S, Eller N, Högenauer C. Non-interventional study evaluating efficacy and tolerability of rifaximin for treatment of uncomplicated diverticular disease. Wien Klin Wochenschr. 2014;126(1–2):9–14. doi:10.1007/s00508-013-0447-7
  • D’Amico F, Fiorini G, Tursi A, et al. Efficacy of a new nutraceutical formulation in patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): a prospective observational study. JGLD. 2020;28:49–52. doi:10.15403/jgld-560
  • Carabotti M, Cuomo R, Barbara G, et al. Demographic and clinical features distinguish subgroups of diverticular disease patients: results from an Italian nationwide registry. United Eur Gastroenterol J. 2018;6(6):926–934. doi:10.1177/2050640618764953
  • Friso Lock* J, Galata* C, Reißfelder C, Ritz JP, Schiedeck T, Germer CT. The indications for and timing of surgery for diverticular disease. Dtsch Arztebl Int. 2020;117(35–36):591–596. doi:10.3238/arztebl.2020.0591
  • Mari GM, Gaia S, Andrea C, et al. Recurrent diverticulitis after elective surgery. Int J Colorectal Dis. 2022;37(10):2149–2155. doi:10.1007/s00384-022-04248-x
  • van de Wall BJM, Draaisma WA, van Iersel JJ, Consten ECJ, Wiezer MJ, Broeders IAMJ. Elective resection for ongoing diverticular disease significantly improves quality of life. Dig Surg. 2013;30(3):190–197. doi:10.1159/000346482